Anticancer research, 0250-7005
Journal
1 - 10 out of 12Page size: 10
Publications
- 2017
- Published
A study of angiogenesis markers in patients with renal cell carcinoma undergoing therapy with sunitinib
Sarah Pirrie & Emilio Porfiri, 1 Jan 2017, In: Anticancer research. 37, 1, p. 253-259 7 p.Research output: Contribution to journal › Article › peer-review
- 2016
- Published
Outcomes Following Interval Debulking Surgery in Primary Peritoneal Carcinoma
Sudha Sundar, 1 Jan 2016, In: Anticancer research. 36, 1, p. 255-259 5 p.Research output: Contribution to journal › Article › peer-review
- 2015
- Published
Survival and toxicity following chemoradiation for carcinoma of the cervix - Impact of multiple-phase treatment and shielding
Sarah Pirrie, 1 Oct 2015, In: Anticancer research. 35, 10, p. 5567-5574 8 p.Research output: Contribution to journal › Article › peer-review
- Published
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression
Paul Foster, Oct 2015, In: Anticancer research. 35, 10, p. 5249-61 13 p.Research output: Contribution to journal › Article › peer-review
- Published
Predictive factors for response to abiraterone in metaststic castration refractory prostate cancer
Sarah Pirrie, Nicholas James, Feb 2015, In: Anticancer research. 35, 2, p. 1057-1063 7 p.Research output: Contribution to journal › Article › peer-review
- 2012
- Published
- 2009
- Published
- Published
STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cells
Paul Foster, 2009, In: Anticancer research. 29, 10, p. 3751-7 7 p.Research output: Contribution to journal › Article › peer-review
- 2008
- Published
A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140
Paul Foster, 2008, In: Anticancer research. 28, 3A, p. 1483-91 9 p.Research output: Contribution to journal › Article › peer-review
- Published
A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer
Paul Foster, 2008, In: Anticancer research. 28, 2A, p. 577-81 5 p.Research output: Contribution to journal › Article › peer-review